Table 2. | Data of skeletal advancement and relapse in all patients and within the different facial types |
| All patients (n = 33) |
Short (n = 2) |
Average (n = 12) |
Long (n = 19) |
P-value | |||
|---|---|---|---|---|---|---|---|
|
Advancement (mm) |
B-point | Mean (SD) | 11.62 (1.41) | 11.45 (1.99) | 11.67 (1.56) | 11.61 (1.36) | 0.88 |
| Min; max | 10.01; 14.75 | 10.04; 12.85 | 10.01; 14.15 | 10.21; 14.75 | |||
| Pogonion | Mean (SD) | 13.51 (2.26) | 12.55 (3.51) | 12.79 (2.27) | 14.06 (2.11) | 0.18 | |
| Min; max | 10.06; 17.33 | 10.06; 15.03 | 10.26; 16.63 | 11.01; 17.33 | |||
|
Relapse (mm) |
B-point | Mean (SD) | -1.31 (0.72) | -1.63 (0.75) | -1.04 (0.57) | -1.45 (0.78) | 0.02a |
| Min; max | -3.17; -0.24 | -2.16; -1.10 | -2.47; -0.29 | -3.17; -0.24 | |||
| Pogonion | Mean (SD) | -1.58 (1.02) | -1.90 (0.72) | -1.00 (0.75) | -1.89 (1.06) | 0.11 | |
| Min; max | -3.86; -0.1 | -2.50; -1.48 | -2.88; -0.2 | -3.86; -0.1 | |||
|
Relapse (%) |
B-point | Mean (SD) | 11.43 (6.4) | 13.88 (4.14) | 8.98 (5.41) | 12.72 (6.9) | 0.04a |
| Min; max | 2.04; 24.44 | 10.96; 16.81 | 2.66; 24.29 | 2.04; 24.44 | |||
| Pogonion | Mean (SD) | 11.76 (7.81) | 15.67 (1.36) | 7.80 (6.02) | 13.85 (8.33) | 0.01a | |
| Min; max | 0.75; 32.49 | 14.71; 16.63 | 1.71; 24.55 | 0.75; 32.49 | |||
aStatistically significant at level P ≤ 0.05, Median tests.
|
.png)